MCA logo
MCA logo

PUBLIC PORTAL

MEDICALLY REVIEWED

The Role of Dupilumab (Dupixent), an IL-4 Receptor Alpha Antagonist, in Atopic Dermatitis

dupilumab dupixent atopic dermatitis eczema
Among the many new drug approved for the use of atopic dermatitis or eczema, dupilumab (Dupixent) is one of them. Find out about its evidence here.

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read: